Literature DB >> 11536240

MIP-1 alpha and MIP-1 beta induction by dengue virus.

T A Spain-Santana1, S Marglin, F A Ennis, A L Rothman.   

Abstract

Dengue virus (DV) infection can result in either a mild febrile illness known as dengue fever (DF) or a life-threatening disease called dengue hemorrhagic fever (DHF). DHF is more prevalent in patients undergoing secondary DV infection. This observation has led to the hypothesis that DHF may be the result of immune reactions to the secondary DV infection; an event termed immunopathology. Two cellular factors, MIP-1 alpha and MIP-1 beta, have been found to be induced by infection with DV. MIP-1 induction by DV infection was observed in a myelomonocytic cell line, as well as in peripheral blood mononuclear cells isolated from a dengue naive donor. MIP-1 induction was not due to factors secreted by infected cells. In fact, replication-competent virus was required to induce MIP-1. Evidence is also provided that MIP-1 genes are expressed in patients with dengue disease. It is hypothesized that these chemokines may have roles in the immunopathology of dengue infections and may contribute to fever and bone marrow suppression observed in patients with DV infections. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536240     DOI: 10.1002/jmv.2037

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  Immunosuppressive effects and mechanisms of leflunomide in dengue virus infection of human dendritic cells.

Authors:  Wan-Lin Wu; Ling-Jun Ho; Pei-Chih Chen; Yi-Ting Tsai; Seng-Ting Hsu; Deh-Ming Chang; Jenn-Haung Lai
Journal:  J Clin Immunol       Date:  2011-08-17       Impact factor: 8.317

2.  Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion.

Authors:  Carey L Medin; Katherine A Fitzgerald; Alan L Rothman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.

Authors:  Yun-Chi Chen; Sheng-Yuan Wang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Association of Intracellular T(H)1-T(H)2 Balance in CD4+ T-cells and MIP-1α in CD8+ T-cells with Disease Severity in Adults with Dengue.

Authors:  Tamilarasu Kadhiravan; Ankit Saxena; Amar Singh; Shobha Broor; Surendra K Sharma; Dipendra K Mitra
Journal:  Immune Netw       Date:  2010-10-31       Impact factor: 6.303

5.  Dengue virus selectively induces human mast cell chemokine production.

Authors:  Christine A King; Robert Anderson; Jean S Marshall
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Elevated levels of soluble ST2 protein in dengue virus infected patients.

Authors:  Aniuska Becerra; Rajas V Warke; Norma de Bosch; Alan L Rothman; Irene Bosch
Journal:  Cytokine       Date:  2008-01-28       Impact factor: 3.861

Review 7.  Dengue virus infection: current concepts in immune mechanisms and lessons from murine models.

Authors:  Rodrigo Guabiraba; Bernhard Ryffel
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

8.  Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo.

Authors:  Aniuska Becerra; Rajas V Warke; Katherine Martin; Kris Xhaja; Norma de Bosch; Alan L Rothman; Irene Bosch
Journal:  J Med Virol       Date:  2009-08       Impact factor: 2.327

9.  Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice.

Authors:  Rodrigo Guabiraba; Rafael Elias Marques; Anne-Gaëlle Besnard; Caio T Fagundes; Danielle G Souza; Bernhard Ryffel; Mauro M Teixeira
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

10.  Susceptibility and response of human blood monocyte subsets to primary dengue virus infection.

Authors:  Kok Loon Wong; Weiqiang Chen; Thavamalar Balakrishnan; Ying Xiu Toh; Katja Fink; Siew-Cheng Wong
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.